The best gift I’ve given recently was a set of beautiful Japanese sculpting tools, which I got for my friend Boaz, who sold ...

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

Vertex Pharmaceuticals Inc. will work with a Watertown biotech on new gene-editing therapies for people with sickle cell ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...

Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and ...

The Killing Sense is set in Paris. At its centre is Galway-born, London-based single mother Kate Wilde, who has managed to ...

MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of ...

Stocks like SH Kelkar and Company, Ashoka Buildcon, Vodafone Idea, Bharti Airtel, Coal India, Power Grid Corporation, Nuvoco ...

Both sides are accusing each other of violations as the deadline nears for Israeli troops to withdraw from Lebanon.